Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrastaging of Early Cancer of the Large Bowel Using Intraoperative Lymphatic Mapping, Sentinel Node Analysis and Blood Testing
NCT00625625Phase 2Unknown
- Sponsor
- Providence Saint John's Cancer Institute
- Start
- Mar 2004
- Primary completion
- Nov 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of isosulfan blue in colorectal cancer (CRC), sponsored by Providence Saint John's Cancer Institute. Status: unknown.
02
Drugs
isosulfan blue
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00625625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625625.